Halozyme Therapeutics Inc. buy Wells Fargo & Company
Start price
07.06.24
/
50%
€47.16
Target price
07.06.25
€53.56
Performance (%)
0.95%
End price
08.06.25
€47.61
Summary
This prediction ended on 08.06.25 with a price of €47.61. During the runtime of the prediction for Halozyme Therapeutics Inc. the price only changed by 0.95%. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Halozyme Therapeutics Inc. | -4.373% | -4.373% | 48.261% |
| iShares Core DAX® | 0.437% | 5.897% | 8.047% |
| iShares Nasdaq 100 | 1.057% | 0.920% | 28.466% |
| iShares Nikkei 225® | 1.769% | 1.228% | 47.574% |
| iShares S&P 500 | 0.368% | 1.920% | 23.200% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target raised by analysts at Wells Fargo & Company from $48.00 to $58.00. They now have an "overweight" rating on the stock.
Ratings data for HALO provided by MarketBeat
In the thread Trading Halozyme Therapeutics Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten